Literature DB >> 22071892

Newborn screening for sickle cell disease: whose reproductive benefit?

Lainie Friedman Ross.   

Abstract

Mesh：

Year:  2011        PMID： 22071892      PMCID： PMC3330207          DOI： 10.1038/ejhg.2011.191

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  9 in total

1.  Health-care providers' views on pursuing reproductive benefit through newborn screening: the case of sickle cell disorders.

Authors:  Yvonne Bombard; Fiona A Miller; Robin Z Hayeems; Brenda J Wilson; June C Carroll; Martha Paynter; Julian Little; Judith Allanson; Jessica P Bytautas; Pranesh Chakraborty
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

2.  Ethical issues in pediatric genetics: views of geneticists, parents and primary care physicians.

Authors:  D C Wertz
Journal:  Health Law J       Date:  1998

3.  Changing perspectives on the benefits of newborn screening.

Authors:  Donald B Bailey; Laura M Beskow; Arlene M Davis; Debra Skinner
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2006

Review 4.  Complications associated with sickle cell trait: a brief narrative review.

Authors:  Geoffrey Tsaras; Amma Owusu-Ansah; Freda Owusua Boateng; Yaw Amoateng-Adjepong
Journal:  Am J Med       Date:  2009-04-24       Impact factor: 4.965

5.  Newborn sickle cell screening in a region of Western New York State.

Authors:  Norma B Lerner; Bridget L Platania; Sandra LaBella
Journal:  J Pediatr       Date:  2008-09-19       Impact factor: 4.406

Review 6.  Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening.

Authors:  Yvonne Bombard; Fiona A Miller; Robin Z Hayeems; Denise Avard; Bartha M Knoppers
Journal:  Eur J Hum Genet       Date:  2010-03-03       Impact factor: 4.246

7.  Cystic fibrosis birth rates in Canada: a decreasing trend since the onset of genetic testing.

Authors:  Annie Dupuis; David Hamilton; David E C Cole; Mary Corey
Journal:  J Pediatr       Date:  2005-09       Impact factor: 4.406

8.  Mothers' accounts of screening newborn babies in Wales (UK).

Authors:  Evelyn P Parsons; Janet T King; Janet A Israel; Don M Bradley
Journal:  Midwifery       Date:  2006-08-22       Impact factor: 2.372

9.  Cystic fibrosis newborn screening: impact on reproductive behavior and implications for genetic counseling.

Authors:  E H Mischler; B S Wilfond; N Fost; A Laxova; C Reiser; C M Sauer; L M Makholm; G Shen; L Feenan; C McCarthy; P M Farrell
Journal:  Pediatrics       Date:  1998-07       Impact factor: 7.124
  9 in total
  5 in total

1.  Reply to Ross' commentary: Reproductive benefit through newborn screening: preferences, policy and ethics.

Authors:  Yvonne Bombard; Fiona A Miller
Journal:  Eur J Hum Genet       Date:  2012-02-29       Impact factor: 4.246

2.  A qualitative study to explore how professionals in the United Kingdom make decisions to test children for a sickle cell carrier status.

Authors:  Melissa Noke; Sarah Peters; Alison Wearden; Fiona Ulph
Journal:  Eur J Hum Genet       Date:  2015-05-27       Impact factor: 4.246

3.  Disparities in current and future childhood and newborn carrier identification.

Authors:  Melissa Noke; Alison Wearden; Sarah Peters; Fiona Ulph
Journal:  J Genet Couns       Date:  2014-07-11       Impact factor: 2.537

Review 4.  Fostering caring relationships: Suggestions to rethink liberal perspectives on the ethics of newborn screening.

Authors:  Simone van der Burg; Anke Oerlemans
Journal:  Bioethics       Date:  2018-03       Impact factor: 1.898

Review 5.  Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics.

Authors:  Tessel Rigter; Lidewij Henneman; Ulf Kristoffersson; Alison Hall; Helger G Yntema; Pascal Borry; Holger Tönnies; Quinten Waisfisz; Mariet W Elting; Wybo J Dondorp; Martina C Cornel
Journal:  Hum Mutat       Date:  2013-07-16       Impact factor: 4.878
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.